<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5210156 Figure_1-A</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Western blot detection of PEX13, ATG7, SMURF1, and FANCC in HeLa/GFP-LC3cells transfected with the indicated siRNA. Asterisk denotes non-specific band.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_1-B</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Representative images of GFP-LC3 colocalization with mCherry-capsid at 10 h after Sindbis virus (strain AO30) infection of HeLa/GFP-LC3 cells treated with the indicated siRNA. siPEX13 oligo #2 is shown; similar results were observed with three other siPEX13oligos. Arrowheads denote representative colocalized GFP-LC3/mCherry-capsid puncta. Scale bars, 10 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_1-C</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Quantification of colocalized GFP-LC3 and mCherry-capsid puncta normalized to the number of mCherry-capsid puncta per cell (% colocalization) in the experiment shown in (B). Bars are mean &#177; SEM of triplicate samples (~100 cells analyzed per sample). Similar results were observed in more than three independent experiments. ***p&lt;0.001; one-way ANOVA with adjustment for multiple comparisons. See Fig EV1A and B for quantification of mCherry-capsid puncta per cell and GFP-LC3 puncta per cell from the same experiment.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_1-D</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Western blot detection of Pex13 in MEFs of indicated genotype. Asterisks denote non-specific bands.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_1-E</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Quantification of colocalized GFP-LC3 and mCherry-capsid puncta normalized to the number of mCherry-capsid puncta per cell (% colocalization) at 8 h after Sindbis virus (AO28 strain) infection in MEFs of the indicated genotype. Bars are mean &#177; SEM of triplicate samples (~100 cells analyzed per sample). Similar results were observed in more than three independent experiments. *p&lt;0.05; two-tailed unpaired t-test. See Fig EV1G and H for quantification of mCherry-capsid puncta per cell and GFP-LC3 puncta per cell from the same experiment.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_1-F</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Western blot detection of p62 and LC3 in MEFs of indicated genotype treated with 100 nM Baf A1 or DMSO vehicle and cultured in normal medium (starvation "-") or EBSS (starvation "+") for 3 h. Similar results were observed in three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_1-G</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Quantification of GFP-LC3 puncta in MEFs of indicated genotype treated with 10 nM Baf A1 or DMSO vehicle and cultured in normal medium or HBSS (starvation "+") for 3 h. Bars are mean &#177; SEM of triplicate samples (~100 cells analyzed per sample). *p&lt;0.05; two-tailed unpaired t-test. NC, nonsilencing control.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_2-A-B</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A. Representative images of Parkin-mediated clearance of mitochondrial outer membrane protein TOMM20 in HeLa/Parkin cells treated with indicated siRNA 16 h after treatment with 10 &#956;M CCCP or DMSO vehicle control. siPEX13 oligo #2 is shown; similar results were observed with three other siPEX13 oligos. Scale bars, 20 &#956;m. B. Quantification of TOMM20 clearance in the experiment shown in (A). Results represent mean &#177; SEM of triplicate samples (~100 cells analyzed per sample). Similar results were observed in more than three independent experiments. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001; one-way ANOVA with adjustment for multiple comparisons.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_2-C-D</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C. Representative images of Parkin-mediated clearance of mitochondrial double-stranded DNA (mtDNA) in HeLa/HA-Parkin cells treated with indicated siRNA 8 h after treatment with 2.5 &#956;M oligomycin and 250 nM antimycin A (OA) or DMSO vehicle control. siPEX13 oligo #1 is shown; similar results were observed with three other siPEX13 oligos. Nuclear DNA staining was masked using DAPI. Scale bars, 20 &#956;m. D. Quantification of mtDNA clearance in the experiment shown in (C). Results represent box plots of ~300 cells analyzed per sample. Whiskers represent 5%-95% range, and each outlier is represented by a dot. Similar results were observed in three independent experiments. ****p&lt;0.0001; Kruskal-Wallis H-test.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_2-E-F</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 2-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E. Representative images of TOMM20 fragmentation or compaction around perinuclear region in MEFs of the indicated genotype 24 h after treatment with 30 &#956;M CCCP or DMSO vehicle control. White lines indicate cell borders. Scale bars, 20 &#956;m. F. Quantification of percentage of cells in experiment shown in (E) with accumulation of fragmented mitochondria after CCCP treatment. Results represent mean &#177; SEM of triplicate samples (~100 cells analyzed per sample). Similar results were observed in three independent experiments. **p&lt;0.01; two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_2-G</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Electron microscopic analysis of E18.5 mouse embryonic liver, heart, and skeletal muscle. Shown are representative images from one mouse. Similar results were observed in three mice per genotype. Arrowheads indicate damaged mitochondria. Scale bars, 1 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_3-A</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Western blot detection of PEX13 in HeLa/Parkin cells transfected with indicated siRNA and siRNA-resistant PEX13 plasmid. To achieve similar PEX13 protein expression levels, 0.75 &#956;g PEX13 I326T and PEX13 W313G plasmids were transfected compared to 0.25 &#956;g WT PEX13. Total plasmid level was adjusted using empty vector. Asterisk denotes non-specific band.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_3-B</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Representative images of Parkin-mediated clearance of TOMM20 in HeLa/Parkin cells treated with PEX13 siRNA and transfected with indicated PEX13 siRNA-resistant plasmid and then treated with CCCP (10 &#956;M, 16 h). Scale bars, 20 &#956;m. See Fig EV3B for representative images of mitochondrial morphology (TOMM20 staining) in control cells treated with DMSO.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_3-D</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Western blot detection of PEX13 expression in wild-type (WT) and PEX13 W313G (W313G) mutant primary human fibroblasts.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_3-E-F</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 3-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E. Representative images of Parkin-mediated clearance of TOMM20 in wild-type (WT) and PEX13 W313G (W313G) mutant primary human fibroblasts treated with Oligomycin (2.5 &#956;M) + Antimycin A (250 nM) for 24 h. Scale bars, 20 &#956;m. W313G cells varied in morphology; outlined cell in upper right panel shows a representative cell with larger size and abnormal mitochondrial morphology (see Fig EV3C for higher resolution imaging) and outlined cell in lower right panel shows a representative cell with accumulation of fragmented mitochondria that would be scored as positive in (F). F. Quantification of experiment shown in (E). Results represent mean &#177; SEM of 5 groups of 10 images of random fields of cells (&gt;350 cells analyzed per sample). Similar results were observed in two independent experiments. ***p&lt;0.0001; two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_4-A-B-C</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C Representative images of PEX13 and PMP70 (A), PEX13 and TOMM20 (B), or PEX13-Flag and WIPI2 (C) colocalization in HeLa/Parkin cells transfected with PEX13 after 4 h DMSO or CCCP treatment. Scale bars, 20 &#956;m (A-B) and 5 &#956;m (C).</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_4-D</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Western blot detection of endogenous PEX13 in HeLa/Parkin cells treated with 10 &#956;M CCCP for the indicated time.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_5-A</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Quantitative real-time PCR detection of mRNA levels for PEX3, PEX13, PEX14, and PEX19 in HeLa cells transfected with the indicated siRNA. ***p&lt;0.001; two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_5-B</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Quantification of Parkin-mediated TOMM20 clearance in HeLa/Parkin cells transfected with the indicated siRNA 16 h after treatment with 10 &#181;M CCCP. Results represent mean &#177; SEM of triplicate samples (~100 cells analyzed per sample). Similar results were observed in three independent experiments. **p&lt;0.01, ***p&lt;0.001; one-way ANOVA with adjustment for multiple comparisons.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_5-C</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Quantification of mtDNA clearance in HeLa/HA-Parkin cells transfected with the indicated siRNA 8 h after treatment with 2.5 &#956;M oligomycin and 250 nM antimycin A (OA). Results represent box plots of ~300 cells analyzed per sample. Whiskers represent 5%-95% range, and each outlier is represented by a dot. Similar results were observed in three independent experiments. ****p&lt;0.0001, NS= not significant; Kruskal-Wallis H-test.</text>
    </passage>
  </document>
  <document>
    <id>5210156 Figure_5-D</id>
    <infon key="sourcedata_document">2445</infon>
    <infon key="doi">10.15252/embr.201642443</infon>
    <infon key="pmc_id">5210156</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Quantification of GFP-LC3 puncta in HeLa/GFP-LC3 cells treated with 10 nM Baf A1 or DMSO vehicle and cultured in normal medium or 3 h HBSS starvation media. Results represent mean &#177; SEM in triplicate samples (~100 cells analyzed per sample). Similar results were observed in three independent experiments. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, NS= not significant; one-way ANOVA with adjustment for multiple comparisons. Statistical analyses refer to the differences between Pex or ATG7 siRNAs vs. NC siRNA within each treatment group.</text>
    </passage>
  </document>
</collection>
